Acura Pharmaceuticals Announces Return of Product Rights from Pfizer
April 10, 2014 at 06:30 AM EDT
Acura Pharmaceuticals (NASDAQ: ACUR) announced today a letter agreement with Pfizer Inc. providing for the termination of Pfizer's ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.